Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)

Cell Death and Disease

January 9, 2025

10.1038/s41419-024-07263-8

Cited by 6

Related Papers

No related papers found

Powered by citation graph analysis